Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Regeneus Ltd. ( (AU:CMB) ) has provided an update.
Cambium Bio Limited, a company involved in the biotechnology sector, has announced a change in its substantial holding status. The company ceased to be a substantial holder due to the expiration of voluntary escrow arrangements related to its merger with Cambium Medical Technologies, LLC. This change affects over 2.4 million ordinary shares, potentially impacting the company’s control over voting interests.
More about Regeneus Ltd.
YTD Price Performance: -30.0%
Average Trading Volume: 20,744
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$5.12M
For an in-depth examination of CMB stock, go to TipRanks’ Stock Analysis page.